NASDAQ:OLMA | Income Statement | Olema Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$57.79M$67.18M-$67.18M$3.98M-$63.2M-$0.61-$0.61104,453,732104,453,732
2026-03-31$49.23M$57.99M-$57.99M$4.9M-$53.09M-$0.52-$0.52102,800,098102,800,098
2025-12-31$43.22M$50.08M-$50.08M$4.02M-$46.06M-$0.51-$0.511,452,9491,452,949
2025-09-30$39.95M$45.88M-$45.88M$3.66M-$42.22M-$0.49-$0.4985,732,22185,732,221
2025-06-30$43.9M$47.86M-$47.86M$4.08M-$43.78M-$0.51-$0.5185,497,42685,497,426
2025-03-31$30.62M$34.87M-$34.87M$4.48M-$30.39M-$0.36-$0.3685,426,22385,426,223
2024-12-31$32.3M$36.77M-$36.77M$3.2M-$33.57M-$0.40-$0.405,549,4415,549,441
2024-09-30$33.23M$37.62M-$37.62M$3.07M-$34.56M-$0.60-$0.6057,262,80357,262,803
2024-06-30$29.11M$33.53M-$33.53M$3.15M-$30.38M-$0.54-$0.5456,282,40256,282,402
2024-03-31$29.88M$34.34M-$34.34M$3.37M-$30.97M-$0.56-$0.5655,574,32455,574,324
2023-12-31$25.87M$30.42M-$30.42M$3.64M-$26.77M-$0.48-$0.483,247,1203,247,120
2023-09-30$19.45M$23.34M-$23.34M$1.84M-$21.5M-$0.48-$0.4844,977,16144,977,161
2023-06-30$17.99M$21.6M-$21.6M$1.51M-$20.1M-$0.49-$0.4940,720,29440,720,294
2023-03-31$22.83M$29.6M-$29.6M$1.32M-$28.29M-$0.70-$0.7040,354,49340,354,493
2022-12-31$21.58M$27.22M-$27.22M$1.04M-$26.18M-$0.65-$0.6565,04265,042
2022-09-30$17.63M$23.22M-$23.22M$502,000.00-$22.72M-$0.57-$0.5740,036,20140,036,201
2022-06-30$27.05M$33.29M-$33.29M$435,000.00-$32.86M-$0.82-$0.8239,918,21939,918,219
2022-03-31$16.01M$23.25M-$23.25M$224,000.00-$23.03M-$0.58-$0.5839,834,61939,834,619
2021-12-31$15.98M$21.76M-$21.76M$119,000.00-$21.64M-$0.55-$0.5573,61773,617
2021-09-30$12.52M$17.76M-$17.76M$49,000.00-$17.71M-$0.45-$0.4539,607,74539,607,745
2021-06-30$11.91M$16.52M-$16.52M$116,000.00-$16.41M-$0.42-$0.4239,415,33039,415,330
2021-03-31$10.69M$15.45M-$15.45M$111,000.00-$15.34M-$0.39-$0.3939,325,79339,325,793
2020-12-31$6.29M$10.13M-$10.13M$0.00-$10.13M$1.87$1.874,403,9254,403,925
2020-09-30$4.67M$7.87M-$7.87M$24,000.00-$7.84M-$3.71-$3.712,617,5432,617,543
2020-06-30$1.95M$2.49M-$2.49M$33,000.00-$2.45M-$0.95-$0.952,593,3162,593,316
2020-03-31$795,000.00$1.04M-$1.04M-$1.69M2,593,316

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$157.7M$178.7M-$178.7M$16.25M-$162.45M$3,000.00-$162.45M-$1.87-$1.8787,006,02787,006,027
2024-12-31$124.52M$142.26M-$142.26M$12.78M-$129.47M$2,000.00-$129.47M-$2.20-$2.2058,743,52258,743,522
2023-12-31$86.14M$104.96M-$104.96M$8.31M$2,000.00-$96.66M-$2.14-$2.1445,247,09845,247,098
2022-12-31$82.27M$106.99M-$106.99M$2.2M$1,000.00-$104.79M-$2.62-$2.6239,995,46039,995,460
2021-12-31$51.1M$71.49M-$71.49M$395,000.00-$71.1M-$1.80-$1.8039,524,27239,524,272
2020-12-31$13.7M$21.53M-$21.53M-$593,000.00-$22.12M-$3.42-$3.427,021,4687,021,468
2019-12-31$3.92M$4.32M-$4.32M$7,000.00-$4.32M-$1.66-$1.662,593,3162,593,316